ArticleJournal of behavioral medicine2026
Bayesian multivariate longitudinal piecewise regression: detecting early onset of cognitive decline.
Article in Journal of behavioral medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Data analysis for behavioral medicine: an introduction to the special issue.Journal of behavioral medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The current paper defines and tests a hierarchical multivariate change point model (HMLCP) to detect a random change point in longitudinal data (subject-specific). Given the large number of random effects that are estimated, we implemented the HMLCP using Bayesian methods. First, we present model parameterization and then applied it in a sample of older adults, to identify the onset of cognitive decline with neurocognitive data collected at the Knight Alzheimer Disease Center. These data presented an ideal case study to test a multivariate random change-point model with a diagnosed sample, to see if the model can detect the disease progression of AD. HMLCP model was sensitive to detect the presence of disease several years before clinical diagnosis. Further, the HMLCP allowed us to describe the sample disease progression, and predict change points at the level of the individual. We demonstrate HMLCP’s flexibility by comparing results from the whole sample with individual subjects and conclude that the HMLCP is a powerful model for estimating multivariate-multilevel unknown change point trajectories.
Indexed as
Identifiers
41417171What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.